To further understand the effect of CXCL3 on the malignant behaviors of HNSCC cells, we used different concentrations of recombinant human CXCL3 to treat HSC4, KB, and CAL27 cells. Here, CXCL3 is linked to head and neck squamous cell carcinoma.